Skip to main content

Part of Cancer staging guidance sheets

Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)

Current Chapter

Current chapter – Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)


Introduction

This is the data sheet for TNM 9th edition staging of the oral cavity and mucosal lip (ICD10 C00.3-5, C02-C06).

For more detailed information regarding TNM staging, please see pages 18-22 of the UICC TNM 9 book.


Stage groupings

Stage Group

T stage

N stage

M stage

Stage 0

Tis

N0

M0

Stage I

T1

N0

M0

Stage II

T2

N0

M0

Stage III

T3

N0

M0

T1, T2, T3

N1

M0

Stage IVA

T4a

N0, N1

M0

T1, T2, T3, T4a

N2

M0

Stage IVB

Any T

N3

M0

T4b

Any N

M0

Stage IVC

Any T

Any N

M1


TNM clinical classification

T - primary tumour

T value

Description

cTX

Primary tumour cannot be assessed

cT0

No evidence of primary tumour

cTis

Carcinoma in situ

cT1

Tumour 2 cm or less in greatest dimension and 5mm or less depth of invasion1,2

cT2

Tumour 2 cm or less in greatest dimension and more than 5mm depth of invasion or, Tumour more than 2 cm but not more than 4 cm in greatest dimension and depth of invasion no more than 10mm

cT3

Tumour more than 2 cm but not more than 4 cm in greatest dimension and depth of invasion more than 10 mm or

 

Tumour more than 4 cm in greatest dimension and not more than 10 mm depth of invasion

cT4a

Tumour more than 4cm in greatest dimension and more than 10 mm depth of invasion or

 

Tumour invades through the cortical bone (with involvement of spongiosa/spongy bone) of the mandible or maxilla or involves the maxillary sinus, or invades the skin of the face2

cT4b

Tumour invades masticator space, pterygoid plates, or skull base, or encases internal carotid artery

Note:

1Superficial erosion alone of bone/tooth socket by gingival primary is not sufficient to classify a tumour as cT4a

2Superficial invasion of adjacent skin (i.e, dry vermillion border of the lip) from mucosal lip is not sufficient to be classified as a T4a tumour

N - regional lymph nodes

N value

Description

cNX

Regional lymph nodes cannot be assessed

cN0

No regional lymph node metastasis

cN1

Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension without extranodal extension

cN2

Metastasis described as:

cN2a - Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension without extranodal extension

 

cN2b - Metasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension without extranodal extension

 

cN2c - Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension without extranodal extension

cN3a

Metastasis in a lymph node more than 6 cm in greatest dimension without extranodal extension

cN3b

Metastasis in a single or multiple lymph node with clinical extranodal extension*

Notes:

*Clinical extranodal extension is defined as the presence of skin involvement or soft tissue invasion with deep fixation to underlying muscle or adjacent anatomical structures or clinical signs of nerve involvement. Imaging is becoming a standard method of detecting unequivocal extranodal extension.

Midline nodes are considered ipsilateral nodes

M - distant metastasis

M value

Description

cM0

No distant metastasis

cM1

Distant Metastasis


TNM pathological classification

pT - primary tumour

The pT categories correspond to the T categories.

pN - regional lymph nodes

Histological examination of a selective neck dissection specimen will ordinarily include 10 or more lymph nodes. Histological examination of a radical or modified radical neck dissection specimen will ordinarily include 15 or more lymph nodes.

pN value

Description

pNX

Regional lymph nodes cannot be assessed

pN0

No regional lymph node metastasis

pN1

Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension without extranodal extension

pN2

pN2a - Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension with extranodal extension or more than 3 cm but not more than 6 cm in greatest dimension without extranodal extension

 

pN2b - Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, without extranodal extension

 

pN2c - Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension without extranodal extension

pN3a

Metastasis in a lymph node more than 6 cm in greatest dimension without pathological extranodal extension

pN3b

Metastasis in a single lymph node more than 3cm in greatest dimension with pathological extranodal extension* OR metastasis in multiple ipsilateral, or any contralateral or bilateral node(s) with pathological extranodal extension*

Note:

*Pathological extranodal extension (pENE) should only be diagnosed when tumour that is present within the confines of a lymph node definitively transgresses through the entire thickness of the lymph node capsule into the surrounding connective tissue, with or without stromal reaction. A soft tissue deposit should be considered as at least one lymph node with extranodal extension if it occurs at a site where a regional lymph node would be expected.


Download

Click on the box below to download a PDF version of this staging sheet:

Last edited: 16 January 2026 3:47 pm

  1. Cancer staging guidance sheets
  2. Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
  4. Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
  5. Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
  6. Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
  7. Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
  8. Stomach (ICD10 C16 - excluding C16.0)
  9. Small intestine (ICD10 C17)
  10. Appendix (ICD10 C18.1)
  11. Colon and rectum (ICD10 C18-C20)
  12. Anal and perianal skin (ICD10 C21)
  13. Liver (ICD10 C22.0)
  14. Intrahepatic bile ducts (ICD10 C22.1)
  15. Gallbladder (ICD10 C23)
  16. Distal extrahepatic bile duct (ICD10 C24.0)
  17. Perihilar bile ducts (ICD10 C24.0)
  18. Ampulla of vater (ICD10 C24.1)
  19. Pancreas (ICD10 C25)
  20. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  21. Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
  22. Lung (ICD10 C34)
  23. Thymus tumours (ICD10 C37.9)
  24. Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
  25. Bone (ICD10 C40, C41)
  26. Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
  27. Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
  28. Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
  29. Carcinoma of skin of the eyelid (ICD10 C44.1)
  30. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  31. Pleural mesothelioma (ICD10 C38.4)
  32. Breast tumours (ICD10 C50)
  33. Vulva (ICD10 C51)
  34. Cervix uteri (ICD10 C53)
  35. Uterine sarcomas
  36. Uterus - endometrium (ICD10 C54.1, C55)
  37. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  38. Gestational trophoblastic neoplasms (ICD10 C58)
  39. Penis tumours (ICD10 C60)
  40. Prostate tumours (ICD10 C61.9)
  41. Testis tumours (ICD10 C62)
  42. Kidney tumours (ICD10 C64)
  43. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  44. Urinary bladder tumours (ICD10 C67)
  45. Urethra tumours (ICD10 C68.0, C61.9)
  46. Carcinoma of conjuctiva (ICD10 C69.0)
  47. Melanoma of conjuctiva (ICD10 C69.0)
  48. Retinoblastoma (ICD10 C69.2)
  49. Melanoma of uvea (ICD10 C69.3-4)
  50. Carcinoma of lacrimal gland (ICD10 C69.5)
  51. Sarcoma of orbit (ICD10 C69.6)
  52. Thyroid gland (ICD10 C73.9)
  53. Adrenal cortex (ICD10 C74.0)
  54. Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
  55. Parathyroid gland (ICD10 C75.0)
  56. Unknown primary - cervical nodes (ICD10 C77.0)
  57. Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
  58. T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
  59. Rhabdomyosarcoma (CTYA)
  60. Chronic lymphocytic leukaemia
  61. Hepatoblastoma (CTYA)
  62. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  63. Medulloblastoma
  64. Multiple myeloma
  65. Neuroblastoma
  66. Neuroendocrine tumours of the foregut
  67. Neuroendocrine tumours of the midgut and hindgut
  68. Non-hodgkin lymphoma (children)
  69. Wilms tumour of the kidney